These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 14614605

  • 1. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, Iwakiri H, Uto H, Kato J, Ido A, Hayashi K, Tsubouchi H.
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [Abstract] [Full Text] [Related]

  • 2. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
    Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, Kohara K, Shigenobu S, Ishibashi K, Arima T.
    Cancer; 2003 Mar 01; 97(5):1253-62. PubMed ID: 12599233
    [Abstract] [Full Text] [Related]

  • 4. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M.
    J Am Coll Surg; 2003 Nov 01; 197(5):759-64. PubMed ID: 14585410
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO, Kim SK, Son BH, Yoo CH, Hong HP, Cho YK, Kim BI.
    Hepatobiliary Pancreat Dis Int; 2009 Dec 01; 8(6):591-6. PubMed ID: 20007075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M.
    Liver Int; 2004 Dec 01; 24(6):625-9. PubMed ID: 15566514
    [Abstract] [Full Text] [Related]

  • 9. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K.
    J Gastroenterol Hepatol; 2010 Mar 01; 25(3):597-604. PubMed ID: 20074153
    [Abstract] [Full Text] [Related]

  • 10. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ.
    Am Surg; 2008 Jul 01; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [Abstract] [Full Text] [Related]

  • 11. Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence.
    Ayav A, Germain A, Marchal F, Tierris I, Laurent V, Bazin C, Yuan Y, Robert L, Brunaud L, Bresler L.
    Am J Surg; 2010 Oct 01; 200(4):435-9. PubMed ID: 20409524
    [Abstract] [Full Text] [Related]

  • 12. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
    Glaiberman CB, Pilgram TK, Brown DB.
    J Vasc Interv Radiol; 2005 Oct 01; 16(10):1341-8. PubMed ID: 16221905
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J, Chen MH, Yang W, Wu W, Yan K.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr 01; 20(4):256-60. PubMed ID: 22964144
    [Abstract] [Full Text] [Related]

  • 14. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
    Chow DH, Sinn LH, Ng KK, Lam CM, Yuen J, Fan ST, Poon RT.
    J Surg Oncol; 2006 Dec 01; 94(7):565-71. PubMed ID: 17048238
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation.
    Yang B, Zou J, Xia J, Ren Z, Gan Y, Wang Y, Zhang B, Ge N, Wang D, Chen Y, Chen R, Li L, Ye S, Wang X.
    Eur J Radiol; 2011 Aug 01; 79(2):196-200. PubMed ID: 20303686
    [Abstract] [Full Text] [Related]

  • 16. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S.
    J Gastroenterol Hepatol; 2009 Feb 01; 24(2):223-7. PubMed ID: 18823439
    [Abstract] [Full Text] [Related]

  • 17. [The factors related to the prognosis of solitary hepatocellular carcinoma after radiofrequency ablation].
    Chung IK, Park MJ, Kwon KT, Park YD, Chung YJ, Jeon SW, Lee MK, Seo HE, Lee YD, Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH.
    Korean J Hepatol; 2005 Dec 01; 11(4):371-80. PubMed ID: 16380666
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G.
    Eur J Gastroenterol Hepatol; 2008 Mar 01; 20(3):196-201. PubMed ID: 18301300
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.